JUSTIN LEGE: Open Payments
NPI 1164810164 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 75 payments from 13 companies in 2025. Trend: 2023 $1,093 · 2024 $1,353 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 24 | $328 |
| Mallinckrodt Hospital Products Inc. | 16 | $224 |
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| Calliditas Therapeutics US Inc. | 4 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Vifor Pharma, Inc. | 4 | $86 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Fresenius USA Marketing, Inc. | 2 | $51 |
| GENZYME CORPORATION | 2 | $39 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
Products named: PURIFIED CORTROPHIN GEL, ACTHAR, LOKELMA, TARPEYO, Veltassa, JYNARQUE, FARXIGA, SHINGRIX.
Industry payments across LA — which companies pay providers there.
